Two Sigma Securities’s Cellectar Biosciences, Inc. Series A Warrants CLRBZ Stock Holding History

Two Sigma Securities’s Portfolio CLRBZ Stock Details CLRBZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-14,221	Closed	-$2K	–	1968
2020 Q4	$2K	Buy	+14,221	New	+$2.07K	﹤0.01%	1635

Other funds holding CLRBZ

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Securities's CLRBZ Position: Q1 2021 in Review

Two Sigma Securities sold out of Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) in Q1 2021, closing a stake of 14,221 shares — an estimated $2K sold.

Two Sigma Securities first reported a position in CLRBZ in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 2 funds tracked by Wall St. Rank hold CLRBZ as of Q1 2021.

Two Sigma Securities reported no remaining Cellectar Biosciences, Inc. Series A Warrants position as of Q1 2021 after selling out during the quarter.
Two Sigma Securities sold 14,221 Cellectar Biosciences, Inc. Series A Warrants shares in Q1 2021, an estimated $2K.
Two Sigma Securities first reported a position in Cellectar Biosciences, Inc. Series A Warrants in Q4 2020 and held it in 1 quarter.
Two Sigma Securities's Cellectar Biosciences, Inc. Series A Warrants position peaked at $2K in Q4 2020.
2 funds tracked by Wall St. Rank held Cellectar Biosciences, Inc. Series A Warrants as of Q1 2021.

Based on Two Sigma Securities's 13F filing for Q1 2021, filed 17 May 2021.